Table 3.
Average preoperative and postoperative VR-12 scores.
| VR-12 | DAIR cohort |
2-Stage exchange cohort |
||||
|---|---|---|---|---|---|---|
| DAIR | Aseptic revision matches | 2-Stage exchange | Aseptic revision matches | |||
| VR-12 MCS Preop | 53.9 ± 11.7 | 54.9 ± 10.8 | P = .72 | 47.6 ± 13.2 | 54.5 ± 10.0 | P = .01 |
| VR-12 MCS Postop | 53.0 ± 12.0 | 54.2 ± 10.2 | P = .63 | 51.6 ± 11.6 | 54.1 ± 10.5 | P = .33 |
| VR-12 PCS Preop | 34.8 ± 11.4 | 34.0 ± 10.7 | P = .78 | 31.6 ± 7.5 | 36.0 ± 11.2 | P = .05 |
| VR-12 PCS Postop | 38.6 ± 13.1 | 39.4 ± 11.9 | P = .79 | 40.0 ± 10.6 | 39.7 ± 11.5 | P = .90 |
| Change in VR-12 MCS | -1.0 ± 13.8 | -0.7 ± 10.9 | P = .91 | 3.9 ± 11.9 | -0.4 ± 8.7 | P = .07 |
| Change in VR-12 PCS | 3.9 ± 11.1 | 5.4 ± 11.6 | P = .57 | 8.4 ± 9.6 | 3.7 ± 14.3 | P = .10 |
Values are presented as mean ± standard deviation.